STOCK TITAN

Can B Corp. - CANB STOCK NEWS

Welcome to our dedicated page for Can B news (Ticker: CANB), a resource for investors and traders seeking the latest updates and insights on Can B stock.

Canbiola, Inc. (OTCQB: CANB) is a prominent developer, manufacturer, and seller of a diverse range of cannabidiol (hemp) based products including oils, creams, moisturizers, chews, isolate, gel caps, and concentrates. The company has established its own line of proprietary products while also exploring synergistic opportunities through acquisitions within the CBD and medical cannabis industry. Hemp CBD, the non-psychoactive component devoid of THC, is utilized for pain relief, inflammation, and wellness programs. The company's wholly owned subsidiary, Pure Health Products, headquartered in Lacey, WA, serves as its primary development laboratory and production facility. Recently, Canbiola rolled out a durable medical device through its Duramed division, available via its doctor network to enhance patient treatment.

Rhea-AI Summary
Can B Corp. secures ownership of two cannabis patents valued at $122 million, potentially up to $750 million, extending to 2035. The patents cover cannabis extracts, liquid formulations, and methods of managing various conditions. Can B plans to monetize these patents in a growing industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary
Can B Corp. announces consolidation of Pure Health Product operations, saving nearly $500,000 annually. Colorado is now the base of operations for all manufacturing and shipping.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
none
-
Rhea-AI Summary
Can B Corp. has announced a newly awarded contract with One Bad Moon Rising and the purchase of 1.8 million pounds of biomass. The biomass is stored in Ft. Morgan, Colorado and is ready for immediate processing. The purchase price of the biomass was $2.7 million, paid with Rule 144 restricted stock. Can B's CEO is excited about the new opportunity and looks forward to utilizing their fully integrated operations to produce isomers. One Bad Moon Rising is impressed with Can B's facilities and is excited to fulfill the demand for isomers with their new contract.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.89%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-31.43%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.63%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What products does Canbiola, Inc. offer?

Canbiola offers a variety of cannabidiol (hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrates.

Where is Canbiola's prime development laboratory and production facility located?

Canbiola's wholly owned subsidiary Pure Health Products is based in Lacey, WA.

What is the focus of Canbiola's Duramed division?

Canbiola's Duramed division has recently introduced a durable medical device through its doctor network to provide patient treatment.

What is the legality status of hemp CBD products?

Hemp CBD, the non-psychoactive component without THC, is legal for pain relief, inflammation, and wellness programs in all 50 states.

How does Canbiola aim to expand its product portfolio?

Canbiola is actively seeking synergistic opportunities for growth through acquisitions in the CBD and medical cannabis industry.

Can B Corp.

OTC:CANB

CANB Rankings

CANB Stock Data

709.59k
51.91M
4.97%
2.51%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Hicksville